Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
PTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading PTX News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.56%16.9014.2%$383.74m
SHPGShire PLC Sponsored ADR
0.17%172.200.4%$215.15m
PRXLPAREXEL International Corporation
0.00%87.017.9%$147.08m
PRGOPerrigo Co. Plc
0.94%75.406.4%$146.12m
MNKMallinckrodt Plc
0.00%44.8517.7%$120.76m
ALRAlere Inc.
0.00%50.232.7%$93.61m
JAZZJazz Pharmaceuticals Plc
0.00%154.862.2%$85.33m
PTLAPortola Pharmaceuticals, Inc.
0.00%54.418.9%$84.74m
UTHRUnited Therapeutics Corporation
0.00%130.9413.9%$75.70m
ENDPEndo International Plc
1.32%11.498.9%$72.80m
HZNPHorizon Pharma plc
0.00%11.477.6%$55.69m
ICPTIntercept Pharmaceuticals, Inc.
1.63%124.0022.1%$51.82m
MDCOMedicines Company
0.00%38.0322.3%$48.56m
CTLTCatalent Inc
0.00%35.752.8%$41.75m
SAGESAGE Therapeutics, Inc.
0.00%76.0111.9%$36.05m

Company Profile

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. The firm distributes its products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.,09LM9R-E